BackHubei Biocause Heilen Pharmaceutical , Ltd. Overview

Hubei Biocause Heilen Pharmaceutical , Ltd. Intangible Assets

Hubei Biocause Heilen Pharmaceutical , Ltd.'s intangible assets is $69M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$69.36M
↑ 0.46% YoYΔ $317803.00 vs prior year quarter

Peer trimmed avg / median

Loading

Hubei Biocause Heilen Pharmaceutical , Ltd. Intangible Assets History

Loading

Hubei Biocause Heilen Pharmaceutical , Ltd. vs. peers: Intangible Assets Comparison

Loading

Hubei Biocause Heilen Pharmaceutical , Ltd. Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Hubei Biocause Heilen Pharmaceutical , Ltd. (301211.SZ) FAQ

Hubei Biocause Heilen Pharmaceutical , Ltd. (301211.SZ) currently reports a intangible assets of $69M as of September 2026. That compares with $69M in the prior-year period — up 0.5% year over year. Use the charts on this page to explore Hubei Biocause Heilen Pharmaceutical , Ltd.'s intangible assets history and peer comparisons.

Hubei Biocause Heilen Pharmaceutical , Ltd.'s intangible assets increased from $69M to $69M — a 0.5% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hubei Biocause Heilen Pharmaceutical , Ltd. reported $69M in intangible assets as of September 2026. That compares with $69M in the prior-year period — up 0.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $69M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hubei Biocause Heilen Pharmaceutical , Ltd., and consider following 301211.SZ for alerts when major investors trade the stock.